New Chapter Website Up & Running

Posted by ISPE Boston
On March 1, 2018

Today’s the day! The Chapter’s new website is up and running. Cleaner, brighter and easier to navigate, the new website makes it even easier for visitors to access the many benefits and resources the Chapter has to offer. View the calendar for upcoming events you won’t want to miss, check the job board for new […]

Rubius Therapeutics Closes $100 Million Financing

Posted by ISPE Boston
On March 1, 2018

Cambridge-based Rubius Therapeutics, a biotech company pioneering a new class of cellular therapies, today announced the successful completion of an oversubscribed $100 million crossover financing. In just under nine months, the company has now raised over $220 million. Rubius has developed the technology to grow, genetically engineer and mature long circulating Red Cell Therapeutics (RCT) […]

Free Access to ISPE Good Practice Guides

Posted by ISPE Boston
On February 27, 2018

Have you taken advantage of ISPE’s latest Member benefit yet? ISPE’s collection of Good Practice Guides are now available to you through ISPE’s new Guidance Document Portal for FREE—valued at more than $3,000. This extensive library of 24 Guides can be viewed in just a few clicks. Access the portal here and log in with your […]

Vertex Wins FDA Approval for New Cystic Fibrosis Drug

Posted by ISPE Boston
On February 21, 2018

Vertex Pharmaceuticals has announced that the FDA approved Symdeko for treating the underlying cause of cystic fibrosis (CF) in certain patients ages 12 and older. Symdeko is Vertex’s third medicine approved to treat the underlying cause of CF. “Today is an exciting day for the CF community. The approval of Symdeko, our third disease-modifying CF […]

AstraZeneca Immunotherapy Drug Earns FDA Approval

Posted by ISPE Boston
On February 21, 2018

AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the FDA has approved Imfinzi for the treatment of certain patients with non-small cell lung cancer (NSCLC), specifically those with unresectable Stage III NSCLC whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. Stage III (locally advanced) NSCLC is […]

Career Workshop Smashes Previous Attendance Record!

Posted by Brian Hagopian
On February 13, 2018

Attendance at this year’s Student Career Workshop on January 27 obliterated all prior attendance records with over 110 participants! We had a star-studded cast of presenters that included hiring managers from Pfizer and Alnylam, career counselors and industry professionals. And we invited several young professionals who had attended prior Career Workshops to act as mentors […]

“Bridging the Gap” at the Student Career Workshop

Posted by Chris Ciampa
On February 8, 2018

As one of almost 20 presenters at the Chapter’s Student Career Workshop on January 27, I had the pleasure of sharing my thoughts with over 100 area students preparing for careers in the life sciences and STEM fields. This annual event is hosted by the Chapter’s Student Development Committee to help students hone the skills […]

Chapter Member Anniversaries: January 2018

Posted by ISPE Boston
On February 6, 2018

Please congratulate the following members celebrating milestone anniversaries in January 2018. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Michael L. Anderson, Critical Process Systems Group Dr. Anthony C. Bevilacqua, Ph.D., Mettler-Toledo Thornton Inc Brian L. Clark, GMP Operations Consulting Andrew A. Coull, J.M. Coull, Inc. Daniel […]

Welcome New Members!

Posted by ISPE Boston
On February 6, 2018

We would like to introduce the members who joined ISPE in January 2018, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

No Paper? No Problem! Lessons Learned Implementing Electronic Documentation

Posted by Kevin Keating
On February 5, 2018

A critical aspect of any cGMP activity is documentation. As the old saying goes, “If it wasn’t written down, it didn’t happen.” But even as so many forms of communication have become electronic, paper-based documentation systems are still common among pharmaceutical companies. The simplicity of paper-based systems is seemingly obvious: all you need is a […]

Page 102 of 118«‹100 101102103 104 ›»